Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis (Q36505502)

14 August 2017

1 reference

title

Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis (English)

1 reference

14 August 2017

1 reference

1

Simone M Cacciò

1 reference

14 August 2017

Edoardo Pozio

2

1 reference

14 August 2017

1 June 2006

1 reference

Expert Review of Anti-infective Therapy

14 August 2017

1 reference

14 August 2017

4

1 reference

14 August 2017

3

1 reference

14 August 2017

429-443

1 reference

Epidemiology of Cryptosporidium: transmission, detection and identification

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Cryptosporidiosis: epidemiology and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Foot and mouth disease and cryptosporidiosis: possible interaction between two emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Foot and mouth disease in livestock and reduced cryptosporidiosis in humans, England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The changing epidemiology of cryptosporidiosis in North West England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Molecular surveillance of Cryptosporidium spp. in raw wastewater in Milwaukee: implications for understanding outbreak occurrence and transmission dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Unravelling Cryptosporidium and Giardia epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Sporadic cryptosporidiosis, North Cumbria, England, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Cryptosporidiosis associated with animal contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The zoonotic transmission of Giardia and Cryptosporidium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Cryptosporidium: a water-borne zoonotic parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Costs of Illness in the 1993 WaterborneCryptosporidiumOutbreak, Milwaukee, Wisconsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Emerging parasite zoonoses associated with water and food

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Zoonotic protozoa: from land to sea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

New genotypes and factors associated with Cryptosporidium detection in mussels (Mytilus spp.) along the California coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Infection with Cryptosporidium hominis and reinfection with Cryptosporidium parvum in a transplanted ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Unique endemicity of cryptosporidiosis in children in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Sporadic cryptosporidiosis case-control study with genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

A review of chemotherapeutic approaches to the treatment of cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Nitazoxanide: a new broad spectrum antiparasitic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Combination drug therapy for cryptosporidiosis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Recent advances in cryptosporidiosis: the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The impact of HIV-protease inhibitors on opportunistic parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The genome of Cryptosporidium hominis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Antiparasitic agent atovaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Gene transfer in the evolution of parasite nucleotide biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Health Sequelae of Human Cryptosporidiosis in Immunocompetent Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Cryptosporidium in foodstuffs—an emerging aetiological route of human foodborne illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Case-control studies of sporadic cryptosporidiosis in Melbourne and Adelaide, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Possible Effectiveness of Clarithromycin and Rifabutin for Cryptosporidiosis Chemoprophylaxis in HIV Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.429

21 January 2018

Identifiers

DOI

10.1586/14787210.4.3.429

1 reference

14 August 2017

1 reference

PubMed ID

16771620